Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Bausch Health Companies	Jazz Pharmaceuticals	Ionis Pharmaceuticals	Ascendis Pharma A/S	Ultragenyx Pharmaceutical
Symbol	NYSE:BHC	NASDAQ:JAZZ	NASDAQ:IONS	NASDAQ:ASND	NASDAQ:RARE
Price Information
Current Price	$32.28	$165.75	$55.30	$155.13	$139.93
52 Week Range	Buy	Buy	Hold	Buy	Buy
MarketRank™
Overall Score	1.7	2.1	1.4	1.3	1.2
Analysis Score	2.3	3.4	3.1	2.5	2.3
Community Score	2.4	3.4	2.3	2.6	3.3
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.8	1.7	1.7	0.8	0.0
Earnings & Valuation Score	3.1	1.9	0.0	0.6	0.6
Analyst Ratings
Consensus Recommendation	Buy	Buy	Hold	Buy	Buy
Consensus Price Target	$31.50	$184.00	$61.00	$183.00	$124.73
% Upside from Price Target	-2.42% downside	11.01% upside	10.31% upside	17.97% upside	-10.86% downside
Trade Information
Market Cap	$11.46 billion	$9.34 billion	$7.79 billion	$8.29 billion	$9.37 billion
Beta	1.47	1.08	1.42	0.77	2.19
Average Volume	4,698,000	847,344	916,050	183,174	460,089
Sales & Book Value
Annual Revenue	$8.60 billion	$2.16 billion	$1.12 billion	$14.98 million	$103.71 million
Price / Sales	1.33	4.32	6.94	553.17	90.33
Cashflow	$12.86 per share	$22.58 per share	$2.25 per share	N/A	N/A
Price / Cash	2.51	7.34	24.55	N/A	N/A
Book Value	$3.22 per share	$54.99 per share	$11.98 per share	$15.87 per share	$11.32 per share
Price / Book	10.02	3.01	4.62	9.78	12.36
Profitability
Net Income	$-1,788,000,000.00	$523.37 million	$303.26 million	$-244,180,000.00	$-402,730,000.00
EPS	$4.43	$14.60	$2.08	($5.25)	($7.36)
Trailing P/E Ratio	N/A	52.29	115.21	N/A	N/A
Forward P/E Ratio	7.42	10.84	N/A	N/A	N/A
P/E Growth	0.54	4.64	N/A	N/A	N/A
Net Margins	-23.92%	7.86%	7.82%	-4,042.79%	-119.19%
Return on Equity (ROE)	173.20%	20.16%	6.57%	-55.72%	-50.69%
Return on Assets (ROA)	4.21%	10.85%	3.39%	-49.42%	-26.87%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	37.16%	0.55%	0.51%	N/A	N/A
Current Ratio	1.20%	3.98%	10.37%	14.80%	4.33%
Quick Ratio	0.94%	3.84%	10.28%	14.80%	4.26%
Ownership Information
Institutional Ownership Percentage	62.92%	95.67%	84.14%	N/A	N/A
Insider Ownership Percentage	12.14%	4.60%	2.40%	40.00%	8.20%
Miscellaneous
Employees	21,700	1,620	817	330	740
Shares Outstanding	355.16 million	56.33 million	140.86 million	53.42 million	66.95 million
Next Earnings Date	5/6/2021 (Estimated)	5/4/2021 (Estimated)	5/5/2021 (Estimated)	4/7/2021 (Estimated)	5/5/2021 (Estimated)
Optionable	Optionable	Optionable	Optionable	Optionable	Optionable

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Premium Research Tools

Market Data and Calendars

Investing Education and Resources